Dr. Ga Won Yim is a dedicated gynecologic oncologist with academic and clinical experience in obstetrics and gynecology. She obtained her MD, Master’s, and PhD in Medical Science from Yonsei University, Republic of Korea, and completed her specialist training in Obstetrics and Gynecology at Yonsei University Severance Hospital. Following her fellowship, she held progressive academic and clinical leadership roles at Yonsei University and Seoul National University Hospital. In addition to her academic pursuits, Dr. Yim has been actively involved in global health projects in low and middle-income countries, serving as an expert committee member for Official Development Assistance (ODA) agencies in Korea, with a particular focus on women’s health and digital applications for cervical cancer screening.
She is currently an executive Council member of the Asian Society of Gynecologic Oncology (ASGO) and previously served as Vice-Chair of the Symptom Benefit Committee of the Korean Gynecologic Oncology Group (KGOG), which conducts multicenter clinical trials. Before joining NUH in 2026, she was an Associate Professor and Chair of the Robotic Surgery Center at Dongguk University Medical Center. Dr. Yim’s sub-specialty interests include minimally invasive surgery, including single-port and robotic procedures. Dedicated to patient-centered care, she firmly believes that tailored counseling is essential to achieving optimal clinical outcomes and enhancing patient well-being.
2025 - Shinpoong Howel Best Poster Award, Korean Society of Gynecologic Oncology
2024 - Corporate Research Grant, Hanmi Science
2023 - Outstanding Faculty Award, Dongguk University Medical Center
2016 - Public Health Medical Research Grant, National Medical Center
2014 - Contribution Award, Journal of Gynecologic Oncology
2013 - Best Scholar day Poster Award, The Graduate School, Yonsei University
2011 - Hyun Mo Kwak Best Scholarship Award, Yonsei University
2010 - Outstanding Thesis Award from The Graduate School, Yonsei University
(Selected Publications)
1. Yim GW, Han KH, Lee ST, Lee M, Kim HS. Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian cancer: a phase 3, double-blind, parallel group, randomized controlled pilot study
BMC Medicine 2026; 24:131
2. Yim GW, Lee J, Yang K, Lee CH, Huy NVQ, Vo MT, Yoon S. A pilot study of upcycled smartphone‐based colposcopy for visual inspection of cervix performed by community healthcare workers in rural Vietnam. Int J Gynaecol Obstet 2025; 168(2):518-524.
3. Kim J, Lee CH, Yim GW. Multimodal Prehabilitation for Gynecologic Cancer Surgery.
Curr Oncol 2025; 32(2):109.
4. Kim JC, Kim YT, Yim GW. Clinical relevance of vaginal natural orifice transluminal endoscopic surgery (vNOTES) in gynecology. Obstet Gynecol Sci. 2024; 67(2):199-211.
5. Park SJ, King TW, Kim T, Lee M, Choi CH, Shim SH, Yim GW, Lee S, Lee EJ, Lim MC, Chang SJ, Lee SJ, Lee SH, Song T, Lee YY, Nam EJ, Kim HS. Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol. BMC Cancer 2022; 22(1):331.
6. Yim GW, Seol A, Chung JY, Kim SI, Kim HS, Chung HH, Kim JW, Park NH, Song YS, Lee M. Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy. Cancer Res Treat 2022; 54(4):1219-1229.
7. Yim GW, Park SJ, Lee EJ, Lee M, Chung HH, Kim JW, Kim HS. Impact of gynecologic hospitalist on patient waiting time at the emergency department in Korea: A retrospective pre-post cohort study. Taiw J Obstet Gynecol 2021; 60(5):851-856.
8. Yim GW, Eoh KJ, Chung YS, Kim SW, Kim S, Nam EJ, Lee JY, Kim YT. Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer. J Minimal Inv Gynecol 2018; 25(5):823-831.
9. Yim GW, Kim HJ, Kim LK, Kim SW, Kim S, Name EJ, Kim YT. Long Non-coding RNA HOXA11 Antisense Promotes Cell Proliferation and Invasion and Predicts Patient Prognosis in Serous Ovarian Cancer. Cancer Res Treat 2017; 49(3):656-668.
10. Yim GW, Eoh KJ, Kim SW, Nam EJ, Kim YT. Malnutrition Identified by the Nutritional Risk Index and Poor Prognosis in Advanced Epithelial Ovarian Carcinoma. Nutr Cancer 2016; 68(5):772-9.
